Broadly Neutralizing Antibodies

Broadly Neutralizing Antibodies (bnAbs) are specialized proteins produced by the immune system that can recognize and block various strains of a virus, such as HIV, HIV, or influenza. Unlike regular antibodies that target specific virus types, bnAbs can bind to conserved regions shared across many different versions, making them effective against multiple variants. Researchers study bnAbs to develop vaccines and therapies that provide broader protection, potentially offering long-term immunity or treatment options for complex and rapidly changing viruses.